03:31 AM EDT, 10/09/2025 (MT Newswires) -- Apogee Therapeutics ( APGE ) said late Wednesday it priced a public offering of nearly 7 million shares at $41 each and, in lieu of stock to certain investors, pre-funded warrants to buy up to 365,853 shares.

The company also granted underwriters a 30-day option to purchase up to an additional 1.1 million shares.

Apogee Therapeutics ( APGE ) expects to raise gross proceeds of about $300 million from the offering, which is anticipated to close on Friday.